{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T20:24:44Z","timestamp":1777321484932,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12936-016-1270-1","type":"journal-article","created":{"date-parts":[[2016,4,19]],"date-time":"2016-04-19T14:59:03Z","timestamp":1461077943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Differential kinetic profiles and metabolism of primaquine enantiomers by human hepatocytes"],"prefix":"10.1186","volume":"15","author":[{"given":"Pius S.","family":"Fasinu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharathi","family":"Avula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babu L.","family":"Tekwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. P. Dhammika","family":"Nanayakkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. M. T.","family":"Bandara Herath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James D.","family":"McChesney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory A.","family":"Reichard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean R.","family":"Marcsisin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud A.","family":"Elsohly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabana I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikhlas A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larry A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,19]]},"reference":[{"key":"1270_CR1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418.","journal-title":"Malar J."},{"key":"1270_CR2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/QCO.0b013e328010b848","volume":"19","author":"BL Tekwani","year":"2006","unstructured":"Tekwani BL, Walker LA. 8-Aminoquinolines: future role as antiprotozoal drugs. Curr Opin Infect Dis. 2006;19:623\u201331.","journal-title":"Curr Opin Infect Dis."},{"key":"1270_CR3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","volume":"75","author":"DR Hill","year":"2006","unstructured":"Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis. Am J Trop Med Hyg. 2006;75:402\u201315.","journal-title":"Am J Trop Med Hyg"},{"key":"1270_CR4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ejmech.2008.08.011","volume":"44","author":"N Vale","year":"2009","unstructured":"Vale N, Moreira R, Gomes P. Primaquine revisited six decades after its discovery. Eur J Med Chem. 2009;44:937\u201353.","journal-title":"Eur J Med Chem"},{"key":"1270_CR5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/1475-2875-10-351","volume":"10","author":"D Fernando","year":"2011","unstructured":"Fernando D, Rodrigo C, Rajapakse S. Primaquine in vivax malaria: an update and review on management issues. Malar J. 2011;10:351.","journal-title":"Malar J."},{"key":"1270_CR6","unstructured":"WHO. Global Plan for Artemisinin Resistance Containment (GPARC). http:\/\/www.wpro.who.int\/mvp\/artemisinin_resistance_containment_2011.pdf Accessed 27 Nov 2015."},{"key":"1270_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/AAC.12.1.51","volume":"12","author":"LH Schmidt","year":"1977","unstructured":"Schmidt LH, Alexander S, Allen L, Rasco J. Comparison of the curative antimalarial activities and toxicities of primaquine and its d and l isomers. Antimicrob Agents Chemother. 1977;12:51\u201360.","journal-title":"Antimicrob Agents Chemother"},{"key":"1270_CR8","doi-asserted-by":"crossref","first-page":"4737","DOI":"10.1128\/AAC.02674-13","volume":"58","author":"ND Nanayakkara","year":"2014","unstructured":"Nanayakkara ND, Tekwani BL, Herath HB, Sahu R, Gettayacamin M, Tungtaeng A, et al. Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers. Antimicrob Agents Chemother. 2014;58:4737\u201344.","journal-title":"Antimicrob Agents Chemother"},{"key":"1270_CR9","doi-asserted-by":"crossref","first-page":"7283","DOI":"10.1128\/AAC.02576-13","volume":"58","author":"D Saunders","year":"2014","unstructured":"Saunders D, Vanachayangkul P, Imerbsin R, Khemawoot P, Siripokasupkul R, Tekwani BL, et al. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (\u2212)-primaquine enantiomers in rhesus macaques (Macaca mulatta). Antimicrob Agents Chemother. 2014;58:7283\u201391.","journal-title":"Antimicrob Agents Chemother"},{"key":"1270_CR10","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1301936","volume":"369","author":"JW Bennett","year":"2013","unstructured":"Bennett JW, Pybus BS, Yadava A, Tosh D, Sousa JC, McCarthy WF, et al. Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N Engl J Med. 2013;369:1381\u20132.","journal-title":"N Engl J Med"},{"key":"1270_CR11","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1475-2875-12-212","volume":"12","author":"BS Pybus","year":"2013","unstructured":"Pybus BS, Marcsisin SR, Jin X, Deye G, Sousa JC, Li Q, et al. The metabolism of primaquine to its active metabolite is dependent on CYP 2D6. Malar J. 2013;12:212.","journal-title":"Malar J."},{"key":"1270_CR12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/1475-2875-13-507","volume":"13","author":"PS Fasinu","year":"2014","unstructured":"Fasinu PS, Tekwani BL, Nanayakkara NP, Avula B, Herath HM, Wang YH, et al. Enantioselective metabolism of primaquine by human CYP2D6. Malar J. 2014;13:507.","journal-title":"Malar J."},{"key":"1270_CR13","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1021\/jm00369a031","volume":"27","author":"R Allahyari","year":"1984","unstructured":"Allahyari R, Strother A, Fraser IM, Verbiscar AJ. Synthesis of certain hydroxy analogues of the antimalarial drug primaquine and their in vitro methemoglobin-producing and glutathione-depleting activity in human erythrocytes. J Med Chem. 1984;27:407\u201310.","journal-title":"J Med Chem"},{"key":"1270_CR14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2125.1984.tb02369.x","volume":"17","author":"GW Mihaly","year":"1984","unstructured":"Mihaly GW, Ward SA, Edwards G, Orme ML, Breckenridge AM. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite. Br J Clin Pharmacol. 1984;17:441\u20136.","journal-title":"Br J Clin Pharmacol"},{"key":"1270_CR15","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1124\/dmd.114.061127","volume":"43","author":"BL Tekwani","year":"2015","unstructured":"Tekwani BL, Avula B, Sahu R, Chaurasiya ND, Khan SI, Jain S, et al. Enantioselective pharmacokinetics of primaquine in healthy human volunteers. Drug Metab Dispos. 2015;43:571\u20137.","journal-title":"Drug Metab Dispos"},{"key":"1270_CR16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/jms.3122","volume":"48","author":"B Avula","year":"2013","unstructured":"Avula B, Tekwani BL, Chaurasiya ND, Nanayakkara NP, Wang YH, Khan SI, et al. Profiling primaquine metabolites in primary human hepatocytes using UHPLC-QTOF-MS with 13C stable isotope labeling. J Mass Spectrom. 2013;48:276\u201385.","journal-title":"J Mass Spectrom"},{"key":"1270_CR17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/jlcr.3039","volume":"56","author":"HM Herath","year":"2013","unstructured":"Herath HM, McChesney JD, Walker LA, Nanayakkara NP. Synthesis of [13C6] primaquine. J Labelled Comp Radiopharm. 2013;56:341\u20133.","journal-title":"J Labelled Comp Radiopharm."},{"key":"1270_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1023\/A:1016311616719","volume":"1","author":"JD McChesney","year":"1984","unstructured":"McChesney JD, Sarangan S. Synthesis of 8-(3-carboxy-l-methyl-propylammo)-6-methoxyquinoline: a newly characterized primaquine metabolite. Pharm Res. 1984;1:96\u20138.","journal-title":"Pharm Res"},{"key":"1270_CR19","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jps.2600720124","volume":"72","author":"CD Hufford","year":"1983","unstructured":"Hufford CD, Clark AM, Quinones IN, Baker JK, McChesney JD. Microbial metabolism studies on the major microbial and mammalian metabolite of primaquine. J Pharm Sci. 1983;72:92\u20134.","journal-title":"J Pharm Sci"},{"key":"1270_CR20","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0090-9556(24)14938-0","volume":"27","author":"RS Obach","year":"1999","unstructured":"Obach RS. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: an examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab Dispos. 1999;27:1350\u20139.","journal-title":"Drug Metab Dispos"},{"key":"1270_CR21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","volume":"10","author":"B Davies","year":"1993","unstructured":"Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res. 1993;10:1093\u20135.","journal-title":"Pharm Res"},{"key":"1270_CR22","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.00015-15","volume":"59","author":"BM Potter","year":"2015","unstructured":"Potter BM, Xie LH, Vuong C, Zhang J, Zhang P, Duan D, et al. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics. Antimicrob Agents Chemother. 2015;59:2380\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1270_CR23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/bmc.1557","volume":"25","author":"B Avula","year":"2011","unstructured":"Avula B, Khan SI, Tekwani BL, Nanayakkara NPD, McChesney JD, Walker LA, et al. Analysis of primaquine and its metabolite carboxyprimaquine in biological samples: enantiomeric separation, method validation and quantification. Biomed Chromatogr. 2011;25:1010\u20137.","journal-title":"Biomed Chromatogr"},{"key":"1270_CR24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tox.2012.01.015","volume":"294","author":"S Ganesan","year":"2012","unstructured":"Ganesan S, Chaurasiya ND, Sahu R, Walker LA, Tekwani BL. Understanding the mechanisms for metabolism-linked hemolytic toxicity of primaquine against glucose 6-phosphate dehydrogenase deficient human erythrocytes: evaluation of eryptotic pathway. Toxicology. 2012;294:54\u201360.","journal-title":"Toxicology"},{"key":"1270_CR25","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1128\/AAC.00015-15","volume":"59","author":"BM Potter","year":"2015","unstructured":"Potter BM, Xie LH, Vuong C, Zhang J, Zhang P, Duan D, et al. Differential CYP 2D6 metabolism alters primaquine pharmacokinetics. Antimicrob Agents Chemother. 2015;59:2380\u20137.","journal-title":"Antimicrob Agents Chemother"},{"key":"1270_CR26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1475-2875-11-259","volume":"11","author":"BS Pybus","year":"2012","unstructured":"Pybus BS, Sousa JC, Jin X, Ferguson JA, Christian RE, Barnhart R, et al. CYP450 phenotyping and accurate mass identification of metabolites of the 8-aminoquinoline, anti-malarial drug primaquine. Malar J. 2012;11:259.","journal-title":"Malar J."},{"key":"1270_CR27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/dmd.105.006767","volume":"34","author":"RS Obach","year":"2006","unstructured":"Obach RS, Reed-Hagen AE, Krueger SS, Obach BJ, O\u2019Connell TN, Zandi KS, et al. Metabolism and disposition of varenicline, a selective \u03b14\u03b22 acetylcholine receptor partial agonist, in vivo and in vitro. Drug Metab Dispos. 2006;34:121\u201330.","journal-title":"Drug Metab Dispos"},{"key":"1270_CR28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1124\/dmd.111.043448","volume":"40","author":"AJ Sadeque","year":"2012","unstructured":"Sadeque AJ, Usmani KA, Palamar S, Cerny MA, Chen WG. Identification of human UDP-glucuronosyltransferases involved in N-carbamoyl glucuronidation of lorcaserin. Drug Metab Dispos. 2012;40:772\u20138.","journal-title":"Drug Metab Dispos"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-016-1270-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T20:21:05Z","timestamp":1748895665000},"score":1,"resource":{"primary":{"URL":"http:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-016-1270-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,19]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1186\/s12936-016-1270-1","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,19]]},"article-number":"224"}}